Time-Resolved Fluorescence Resonance Energy Transfer Technology: Principles, Applications, and Recent Advances

Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) is a highly sensitive biophysical technique that combines time-resolved fluorescence detection with the principles of Förster resonance energy transfer. This technology utilizes lanthanide chelates (e.g., europium Eu³⁺, terbium Tb³⁺) as donors and organic fluorescent dyes as acceptors to detect molecular interactions based on the occurrence of energy transfer. By employing time-delayed detection to eliminate short-lived background fluorescence interference, TR-FRET enables no-wash, homogeneous, and high-throughput precision detection in complex biological samples. With its ultra-high sensitivity, wide dynamic range, and excellent anti-interference capability, TR-FRET has become a core technical tool in drug screening, molecular interaction studies, and signal pathway analysis.

TR-FRET is based on two fundamental technical principles: Förster resonance energy transfer (FRET) and time-resolved fluorescence (TRF). FRET describes a non-radiative energy transfer phenomenon: when the donor fluorescent molecule is in an excited state, if the acceptor fluorescent molecule is sufficiently close in space (within a range of 1-10 nanometers), the donor's excitation energy can be directly transferred to the acceptor through dipole-dipole interactions, causing the acceptor to emit characteristic fluorescence. The energy transfer efficiency is inversely proportional to the sixth power of the donor-acceptor distance, making FRET an "optical molecular ruler" for detecting molecular interactions.

However, the sensitivity of traditional FRET technology is severely limited by short-lived background signals such as autofluorescence and scattered light in biological samples. TRF technology addresses this issue by using lanthanide elements as donors. Lanthanide elements (e.g., europium, terbium) emit fluorescence signals that can last for milliseconds after excitation, whereas the half-life of background fluorescence is only at the nanosecond level. During detection, the instrument introduces a time delay of approximately 50-150 microseconds after pulsed excitation, allowing all short-lived background signals to completely decay before collecting the fluorescence signals from the donor and acceptor. This "time-gating" strategy significantly reduces background noise, achieving a leap in detection signal-to-noise ratio.

TR-FRET detection results are typically expressed as the ratio of acceptor fluorescence to donor fluorescence (e.g., 665 nm/620 nm). The introduction of ratio signals eliminates interference from factors such as pipetting errors, fluorescence quenching, and well-to-well variations, further improving data stability and reliability.

The performance of TR-FRET highly depends on the proper matching of donor and acceptor fluorescent molecules. Common donors include chelates or cryptates of europium (Eu³⁺) or terbium (Tb³⁺), with excitation wavelengths around 320-340 nm and emission peaks at approximately 620 nm (Eu³⁺) and 545 nm (Tb³⁺), respectively. The large Stokes shift and sharp emission peaks of lanthanide elements make their signals easy to distinguish from background. Common acceptors include red fluorescent dyes (e.g., XL665, d2, allophycocyanin APC, Alexa Fluor 647) and green fluorescent dyes (e.g., fluorescein, GFP), whose absorption spectra must sufficiently overlap with the donor's emission spectrum to achieve efficient FRET energy transfer. Different donor-acceptor combinations are suitable for different detection scenarios. For example, Tb³⁺'s multiple emission peaks allow it to serve as a donor for both green and red acceptors, enhancing the flexibility of TR-FRET in multiplex detection.

Compared to traditional detection methods, TR-FRET exhibits significant advantages across multiple dimensions. Its ultra-low background noise characteristic stems from the elimination of short-lived autofluorescence through time-delayed detection, reducing background signals to less than 1/100 of those in conventional fluorescence methods. The detection limit can reach picomolar or even femtomolar levels, with a linear dynamic range covering 4-5 orders of magnitude, meeting the needs of simultaneous detection of high- and low-abundance molecules. The homogeneous, no-wash detection mode eliminates complex washing and separation steps, simplifying the workflow, reducing human error, and shortening detection time—typically completed within 1 hour. The reaction system can be miniaturized to 384-well or even 1536-well plates, with sample consumption as low as 10 microliters per well, making it highly compatible with automated liquid handling systems and high-throughput screening platforms.

TR-FRET technology has developed an extremely wide range of applications in life science research and drug discovery.

In protein-protein interaction studies, TR-FRET directly detects the formation and dissociation of complexes by labeling two interacting proteins with donor and acceptor, respectively. For example, researchers have established a TR-FRET high-throughput screening method targeting the FAK-paxillin interaction to identify small-molecule inhibitors of this protein-protein interaction. In more extreme miniaturization efforts, researchers successfully compressed the detection system to 1536-well plates to measure the protein-protein interaction between SYK and FCER1G, achieving a Z' factor greater than 0.8 and a signal-to-background ratio exceeding 15.

In kinase activity assays and inhibitor screening, TR-FRET directly reports kinase activity by detecting phosphorylated substrates, eliminating the need for radioactive labeling and removing interference from compound autofluorescence through time-resolved detection. As of October 2025, 94 protein kinase inhibitors have been approved by the FDA, and TR-FRET kits are widely used in the screening of new inhibitors.

In GPCR signal transduction studies, competitive cAMP TR-FRET detection kits have become the gold standard for analyzing Gs/Gi pathway activity, with a dynamic range of ~4 orders of magnitude. In targeted protein degradation (PROTAC) research, TR-FRET can be used to detect the formation of ternary complexes—E3 ligase-target protein-PROTAC assemblies—providing a quantitative method with direct readouts for the screening and optimization of PROTAC molecules. TR-FRET also demonstrates strong adaptability and flexibility in biomarker quantification, epigenetic research, and cellular target engagement analysis.

In recent years, the TR-FRET technology system has continued to expand and deepen. At the technical support level, microplate readers supporting TR-FRET detection have evolved from dedicated filter-based devices to modular platforms compatible with multimodal detection, further lowering the technical barrier. At the reagent system level, optimized ready-to-use TR-FRET kinase assay kits now cover more than 150 serine/threonine kinases and a wide range of tyrosine kinase families. The proprietary HTRF® system, which encapsulates lanthanide elements in cryptates, achieves ultra-strong tolerance of donors to environmental factors and has been cited in over 10,000 scientific publications worldwide.

In the development of new applications, TR-FRET has been introduced into cutting-edge fields such as PROTAC ternary complex detection and intracellular target engagement analysis. Meanwhile, researchers are working to develop single fluorescent tracers that can be cross-used between TR-FRET and NanoBRET detection platforms to reduce costs and enhance data comparability across platforms. In the field of AI-assisted drug discovery, the high-quality, high-throughput, and highly reproducible bioactivity data generated by TR-FRET are gradually becoming an important data source for AI model training and validation.

Successful application of TR-FRET technology requires rigorous experimental design across multiple aspects. At the instrument level, TR-FRET detection requires a microplate reader equipped with time-resolved detection capabilities—high-sensitivity filters and sufficiently intense pulsed light sources are essential for obtaining high-quality data. At the labeling strategy level, the connection method for donors and acceptors (direct covalent labeling, biotin-streptavidin-mediated indirect labeling, or antibody-mediated immunocapture) must be carefully selected and optimized based on the properties of the target molecules and the experimental system. At the data interpretation level, ratio signals rather than absolute fluorescence intensities from individual channels should always be used as the basis for analysis, with complete control experiments—including donor-only controls (confirming no background), acceptor-only controls (excluding direct excitation), and full-block controls (determining the signal window under complete displacement conditions).

TR-FRET technology integrates the distance sensitivity of Förster resonance energy transfer with the background elimination capability of time-resolved fluorescence, forming a highly sensitive, simple-to-operate, and widely adaptable molecular interaction detection platform. From basic protein-protein interaction studies to high-throughput drug screening, from kinase activity analysis to PROTAC ternary complex detection, the application boundaries of TR-FRET in the biotech industry continue to expand. With advancements in detection instruments, improvements in reagent systems, and deep integration with new drug development technologies (e.g., PROTAC and AI drug screening), TR-FRET is poised to play an irreplaceable core role in a broader range of biological research and drug discovery scenarios.